Challenging the Standard Immunogenicity Assessment Approach: 1-Tiered ADA Testing Strategy in Clinical Trials.
Lai CH, Chen M, Fraser S, Wang J, McAfee S, Speaks E, Simeone N, Rodriguez J, Stefan C, DeStefano L, Elango C, Andisik MD, Sumner G, Zhao A, Irvin SC, Torri A, Partridge MA.
Lai CH, et al. Among authors: torri a.
AAPS J. 2024 Dec 12;27(1):11. doi: 10.1208/s12248-024-00993-9.
AAPS J. 2024.
PMID: 39663329